ArticleCancers2020

The 21-Gene Recurrence Score Assay and Prediction of Chemotherapy Benefit: A Propensity Score-Matched Analysis of the SEER Database.

In Sil Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.